92 related articles for article (PubMed ID: 27278934)
1. Mortality and illicit drug dependence among hemodialysis patients in the United States: a retrospective cohort analysis.
Grubbs V; Vittighoff E; Grimes B; Johansen KL
BMC Nephrol; 2016 Jun; 17(1):56. PubMed ID: 27278934
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic microangiopathy in United States long-term dialysis patients.
Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
[TBL] [Abstract][Full Text] [Related]
3. Quality Improvement Targets for Regional Variation in Surgical End-Stage Renal Disease Care.
Zarkowsky DS; Hicks CW; Arhuidese I; Canner JK; Obeid T; Qazi U; Schneider E; Abularrage CJ; Black JH; Freischlag JA; Malas MB
JAMA Surg; 2015 Aug; 150(8):764-70. PubMed ID: 26107005
[TBL] [Abstract][Full Text] [Related]
4. [REIN Report 2011--summary].
Couchoud C; Lassalle M; Jacquelinet C
Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
[TBL] [Abstract][Full Text] [Related]
5. Survival by time of day of hemodialysis: analysis of United States Renal Data System Dialysis Morbidity and Mortality Waves III/IV.
Abbott KC; Reynolds JC; Trespalacios FC; Cruess D; Agodoa LY;
Am J Kidney Dis; 2003 Apr; 41(4):796-806. PubMed ID: 12666066
[TBL] [Abstract][Full Text] [Related]
6. Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study.
Abbott KC; Glanton CW; Trespalacios FC; Oliver DK; Ortiz MI; Agodoa LY; Cruess DF; Kimmel PL
Kidney Int; 2004 Feb; 65(2):597-605. PubMed ID: 14717930
[TBL] [Abstract][Full Text] [Related]
7. Patient characteristics and outcomes by GN subtype in ESRD.
O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1170-8. PubMed ID: 26092830
[TBL] [Abstract][Full Text] [Related]
8. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.
Winkelmayer WC; Chang TI; Mitani AA; Wilhelm-Leen ER; Ding V; Chertow GM; Brookhart MA; Goldstein BA
Am J Kidney Dis; 2015 Jul; 66(1):106-13. PubMed ID: 25943715
[TBL] [Abstract][Full Text] [Related]
9. Reuse-associated mortality in incident hemodialysis patients in the United States, 2000 to 2001.
Fan Q; Liu J; Ebben JP; Collins AJ
Am J Kidney Dis; 2005 Oct; 46(4):661-8. PubMed ID: 16183421
[TBL] [Abstract][Full Text] [Related]
10. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
[TBL] [Abstract][Full Text] [Related]
11. Comorbidity ascertainment from the ESRD Medical Evidence Report and Medicare claims around dialysis initiation: a comparison using US Renal Data System data.
Krishnan M; Weinhandl ED; Jackson S; Gilbertson DT; Lacson E
Am J Kidney Dis; 2015 Nov; 66(5):802-12. PubMed ID: 26015277
[TBL] [Abstract][Full Text] [Related]
12. Correlates of poor glycemic control among patients with diabetes initiating hemodialysis for end-stage renal disease.
Rhee JJ; Ding VY; Rehkopf DH; Arce CM; Winkelmayer WC
BMC Nephrol; 2015 Dec; 16():204. PubMed ID: 26645204
[TBL] [Abstract][Full Text] [Related]
13. Duration of end-stage renal disease and kidney transplant outcome.
Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
[TBL] [Abstract][Full Text] [Related]
14. Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival.
Abbott KC; Agodoa LY
Clin Nephrol; 2002 Mar; 57(3):208-14. PubMed ID: 11924752
[TBL] [Abstract][Full Text] [Related]
15. Survival differences between peritoneal dialysis and hemodialysis among "large" ESRD patients in the United States.
Stack AG; Murthy BV; Molony DA
Kidney Int; 2004 Jun; 65(6):2398-408. PubMed ID: 15149353
[TBL] [Abstract][Full Text] [Related]
16. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
[TBL] [Abstract][Full Text] [Related]
17. Association Between Starting Hemodialysis for End-Stage Renal Disease and Incident Cataract Surgery: A 12-Year Nationwide Cohort Study.
Rim TH; Yoon CY; Park HW; Chung EJ
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1112-9. PubMed ID: 26975022
[TBL] [Abstract][Full Text] [Related]
18. Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009.
Butler AM; Olshan AF; Kshirsagar AV; Edwards JK; Nielsen ME; Wheeler SB; Brookhart MA
Am J Kidney Dis; 2015 May; 65(5):763-72. PubMed ID: 25662835
[TBL] [Abstract][Full Text] [Related]
19. Mortality and complications after hip fracture among elderly patients undergoing hemodialysis.
Lin JC; Liang WM
BMC Nephrol; 2015 Jul; 16():100. PubMed ID: 26149489
[TBL] [Abstract][Full Text] [Related]
20. Effect of comorbidity on the increased mortality associated with early initiation of dialysis.
Kazmi WH; Gilbertson DT; Obrador GT; Guo H; Pereira BJ; Collins AJ; Kausz AT
Am J Kidney Dis; 2005 Nov; 46(5):887-96. PubMed ID: 16253729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
